Hybio Pharmaceutical (300199) — Cash Flow Quality Index
Hybio Pharmaceutical (300199) has a Cash Flow Quality Index of 1.54x as of June 2025. Operating cash flow of CN¥116.72 Million exceeds net income of CN¥75.60 Million, indicating high earnings quality where cash backs reported profits. Explore 300199 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hybio Pharmaceutical Cash Flow Quality Index (2008–2021)
Historical Cash Flow Quality Index for Hybio Pharmaceutical across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hybio Pharmaceutical (300199) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hybio Pharmaceutical (2008–2021)
Year-by-year earnings quality comparison for Hybio Pharmaceutical. For live market cap and the full company financial profile, see Hybio Pharmaceutical (300199) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 5.52x | CN¥156.83 Million | CN¥28.44 Million | ▲ +750.8% |
| 2017 | 0.65x | CN¥213.74 Million | CN¥329.72 Million | ▼ -36.2% |
| 2016 | 1.02x | CN¥296.41 Million | CN¥291.92 Million | ▲ +123.3% |
| 2015 | 0.45x | CN¥138.84 Million | CN¥305.34 Million | ▼ -49.2% |
| 2014 | 0.89x | CN¥153.43 Million | CN¥171.56 Million | ▼ -24.3% |
| 2013 | 1.18x | CN¥153.48 Million | CN¥129.93 Million | ▲ +21.7% |
| 2012 | 0.97x | CN¥87.19 Million | CN¥89.80 Million | ▲ +7.8% |
| 2011 | 0.90x | CN¥72.48 Million | CN¥80.47 Million | ▼ -13.0% |
| 2010 | 1.03x | CN¥54.69 Million | CN¥52.85 Million | ▲ +40.2% |
| 2009 | 0.74x | CN¥26.11 Million | CN¥35.37 Million | ▼ -68.0% |
| 2008 | 2.30x | CN¥45.75 Million | CN¥19.86 Million | — |